Endo Health Solutions Inc (ENDP): Today's Featured Health Care Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Endo Health Solutions ( ENDP) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.3%. By the end of trading, Endo Health Solutions fell $1.34 (-3.5%) to $36.87 on heavy volume. Throughout the day, 4,137,453 shares of Endo Health Solutions exchanged hands as compared to its average daily volume of 2,433,800 shares. The stock ranged in price between $36.64-$38.25 after having opened the day at $36.97 as compared to the previous trading day's close of $38.21. Other companies within the Health Care sector that declined today were: Oculus Innovative ( OCLS), down 16.0%, Synta Pharmaceuticals ( SNTA), down 13.4%, Cormedix ( CRMD), down 12.5% and Coronado Biosciences ( CNDO), down 10.2%.
  • EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. Endo Health Solutions has a market cap of $4.2 billion and is part of the drugs industry. Shares are up 44.6% year to date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Endo Health Solutions a buy, 3 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Endo Health Solutions as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity.

On the positive front, Affymax ( AFFY), down 25.2%, Alexza Pharmaceuticals ( ALXA), down 22.1%, ICU Medical ( ICUI), down 12.7% and Clovis Oncology ( CLVS), down 12.4% , were all gainers within the health care sector with Herbalife ( HLF) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

null

More from Markets

Jim Cramer: Kimberly Clark's Quarter Was Better Than Procter & Gamble's

Jim Cramer: Kimberly Clark's Quarter Was Better Than Procter & Gamble's

Dow Makes Move Higher as Bond Yields Hover Near 3% Threshold

Dow Makes Move Higher as Bond Yields Hover Near 3% Threshold

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)

The Stock Market Isn't Rigged, Just Look At The Odds (VIDEO)

Let the Najarian Brothers Help You Generate Income With Options

Let the Najarian Brothers Help You Generate Income With Options

All Investors Can Trade Options, Just Ask the Najarian Brothers WATCH VIDEO

All Investors Can Trade Options, Just Ask the Najarian Brothers WATCH VIDEO